Cibus, Inc. (CBUS) vs PolyPid Ltd. (PYPD)

Cibus, Inc. and PolyPid Ltd. are both Biotechnology companies. Cibus, Inc. and PolyPid Ltd. are of similar size ($114.6M and $108.9M). PolyPid Ltd. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cibus, Inc. leads on 7 and PolyPid Ltd. on 5.

Valuation

Metric CBUS PYPD Biotechnology median
P/E n/m n/m 7.88
P/S 27.02 n/m 11.47
P/B 7.93 21.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.56 n/m 10.73
Earnings yield (107.84%) (28.35%) (28.84%)
Free cash flow yield (39.41%) (65.07%) (23.03%)

Profitability

Metric CBUS PYPD Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (1,450.59%) 0.00% 0.00%
Net margin (2,258.89%) 0.00% 0.00%
Free cash flow margin (1,064.60%) 0.00% 0.00%
Return on equity (219.97%) (243.59%) (57.72%)
Return on assets (29.77%) (119.05%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBUS PYPD Biotechnology median
Revenue growth (TTM) (10.30%) — 5.64%
EPS growth (last fiscal year) 74.33% 57.43% —
Revenue growth, 5-year CAGR (31.34%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 1.35 4.73
Net debt to EBITDA (0.28) 0.39 0.96

Dividend

Metric CBUS PYPD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CBUS PYPD Biotechnology median
Market cap 114.64m 108.87m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack